Jo Chien
University of California, San Francisco
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jo Chien as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:09 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06215469 · Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)University of California, San Francisco · active not recruiting · Breast Cancer, Early-stage Breast Cancer, Hair Loss · principal investigator
- Ph2NCT03094052 · Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and NeratinibUniversity of California, San Francisco · completed · HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 · principal investigator
- Ph1NCT01676753 · Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast CancerJo Chien · completed · Advanced or Metastatic Breast Cancer, Triple Negative Breast Cancer · principal investigator
- N/ANCT01384526 · Investigating the Impact of Tamoxifen Therapy on Ovarian AgingUniversity of California, San Francisco · completed · Breast Cancer, Fertility · principal investigator
- Ph1NCT01235897 · MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor MalignanciesUniversity of California, San Francisco · completed · Advanced Solid Tumors, Tumors, Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:09 UTC. The ranking covers the 200 most relevant of 64 PubMed records, and a shared surname and initials can bring in a namesake. All 64 on PubMed
- The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.Cell Metab · 2013765 citationsRCR 22.6
- Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.Ann Intern Med · 2013441 citationsRCR 15.1
- Oral GS-5806 activity in a respiratory syncytial virus challenge study.N Engl J Med · 2014290 citationsRCR 10.3
- 244 citationsRCR 6.0
- Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.Lancet Respir Med · 2017234 citationsRCR 8.2
- Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant · 2016172 citationsRCR 7.4
- Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.Clin Infect Dis · 2000136 citationsRCR 4.6
- Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.Clin Cancer Res · 2017122 citationsRCR 3.5
- Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.J Natl Cancer Inst · 2010103 citationsRCR 2.6
- A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes.Diabetes Obes Metab · 201198 citationsRCR 2.9